Literature DB >> 6936717

Agranulocytosis associated with carbamazepine, and a positive reaction with anti-lymphoid leukaemia antiserum during recovery.

C W Owens, N E Parker, P P Nunn, J Davies.   

Abstract

Carbamazepine is a valuable drug in the treatment of trigeminal neuralgia and temporal lobe epilepsy. Rarely agranulocytosis has been described associated with its use but in this further non-fatal case a new finding of a positive reaction with anti-lymphoid leukaemia anti-serum was seen during the recovery phase. A brief review of 18 cases in the literature is provided and it is noted that 94% of reported cases are over the age of 45 years. The significance of the haematological finding is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6936717      PMCID: PMC2425917          DOI: 10.1136/pgmj.56.659.665

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

Review 1.  Drugs 5 years later: carbamazepine.

Authors:  W E Crill
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

2.  Carbamazepine in the treatment of neuralgia. Use of side effects.

Authors:  J M Killian; G H Fromm
Journal:  Arch Neurol       Date:  1968-08

3.  Clinical trials of tegretol in trigeminal neuralgia.

Authors:  E H Davis
Journal:  Headache       Date:  1969-04       Impact factor: 5.887

4.  Tegretol in trigeminal neuralgia with special reference to hematopoietic side effects.

Authors:  J M Killian
Journal:  Headache       Date:  1969-04       Impact factor: 5.887

5.  Aplastic anaemia following the administration of tegretol.

Authors:  G W Donaldson; J G Graham
Journal:  Br J Clin Pract       Date:  1965-12

6.  No proven relationship of carbamazepine therapy to blood dyscrasias.

Authors:  S Livingston; L Pauli; I Pruce
Journal:  Neurology       Date:  1978-01       Impact factor: 9.910

7.  Use of carbamazepine in epilepsy. Results in 87 patients.

Authors:  S Livingston; C Villamater; Y Sakata; L L Pauli
Journal:  JAMA       Date:  1967-04-17       Impact factor: 56.272

8.  Adverse reactions to carbamazepine (tegretol).

Authors:  S S Al-Ubaidy; F F Nally
Journal:  Br J Oral Surg       Date:  1976-03

9.  Target cell in chronic myeloid leukaemia and its relationship to acute lymphoid leukaemia.

Authors:  G Janossy; M Roberts; M F Greaves
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

10.  [Pancytopenia with fatal course during treatment with carbamazepine (Tegretol)].

Authors:  A E Saleh; D E Mendes de Leon
Journal:  Ned Tijdschr Geneeskd       Date:  1968-11-16
View more
  2 in total

Review 1.  Anticonvulsant drugs and hematological disease.

Authors:  A Verrotti; A Scaparrotta; S Grosso; F Chiarelli; G Coppola
Journal:  Neurol Sci       Date:  2014-03-12       Impact factor: 3.307

2.  The Co-Existence of Agranulocytosis and Stevens-Johnson Syndrome (SJS) in Carbamazepine Therapy: A Case Report.

Authors:  Saima Batool; Diana Voloshyna; Muhammad Usama; Muhammad Suleman; Qudsia I Sandhu; Laxman Nepal; Naglaa G Ghobriel; Jaina Mengar; Ahmed Soodod Mohammed Rasmy
Journal:  Cureus       Date:  2022-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.